We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
22 hedge funds and large institutions have $9.58M invested in Arcturus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
37% more capital invested
Capital invested by funds: $6.98M → $9.58M (+$2.59M)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
22% more funds holding
Funds holding: 18 → 22 (+4)
2.44% more ownership
Funds ownership: 7.65% → 10.09% (+2.4%)
Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
4
Closed
3
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$55K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$274K |
| 3 |
JP Morgan Chase
New York
|
+$66.7K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$45.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$21.1K |
